Can We Offset Local Recurrence in Locally Advanced Non–Small Cell Lung Cancer? The Merry-Go-Round of Radiation Dose Escalation and Stubborn Outcomes First-Line Nivolumab Plus Relatlimab Versus ...
MedPage Today on MSN
New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果